L 365260; (R)-L 365260;Urea,N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(3-methylphenyl)-,(R)-; 1H-1,4-Benzodiazepine, urea deriv.;Urea,N-[(3R)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)-; 

Ardeparin sodium; CY 216; Kabi 2165;Nadroparine; Reviparin; Liquaemin; Clivarin;(4S,6R)-6-[(2R,4R)-4,
6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3,
4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate; Reviparin sodium; Dalteparin sodium; 

UROKINASE UPA 2-CHAIN;Urokinase;UROKINASE (MIXED);UROKINASE, PLASMINOGEN ACTIVATOR, LOW MOLECULAR WEIGHT;UROKINASE, LOW MW (URINE);UROKINASE 2-CHAIN;UROKINASE, HIGH MOLECULAR WEIGHT;EC 3.4.99.26;UROKINASE, SCU-PA; 

Urokinase;Urokinase plasminogen activator;-;